NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Awarded by NHS England · 2023-10-27T13:50:09+01:00 · £624,000,000
Description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East). …
- Buyer
- NHS England
- Value
- £624,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2023-10-27T13:50:09+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.